Stockreport

HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology [Yahoo! Finance]

HUTCHMED (China) Limited - American Depositary Shares  (HCM) 
NASDAQ:AMEX Investor Relations: chi-med.com/investors/information-for-shareholders
PDF — Presentations at EHA showcased subgroup analyses demonstrating consistent benefits regardless of prior lines of therapies or prior TPO/TPO-RA exposure — — Data supp [Read more]